Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Loading
Loading
Home›
Research›
Investment Firms›
IndieBio
AddedFeb 13, 2024
UpdatedJul 16, 2026
IndieBio

IndieBio

Operating

IndieBio: The leading biotech startup accelerator powered by SOSV.

Location
San Francisco, CA, US
Founded
2014
Firm
Compare
Portfolio
Fundraising
Employees
News
Website

Investments

Sun Genomics
Sun Genomics
Series B

Total Raised

$12.2M

Rounds

9

Series BDecember 2023
unlocked labs
unlocked labs
Seed

Total Raised

$1.7M

Rounds

8

SeedDecember 2023
Prellis Biologics
Prellis Biologics
Series C

Total Raised

$79.4M

Rounds

11

Series CNovember 2023
Hypercell Technologies
Hypercell Technologies
Pre-Seed

Total Raised

$1M

Rounds

2

SeedNovember 2023
Lillianah
Lillianah

Total Raised

$40k

Rounds

3

SeedOctober 2023
SeedFebruary 2023
RizLab Health
RizLab Health
Angel

Total Raised

$331k

Rounds

5

Convertible NoteOctober 2023
BioAesthetics
BioAesthetics
Series A

Total Raised

$6.7M

Rounds

7

Convertible NoteSeptember 2023
Gatehouse Bio
Gatehouse Bio
Series A

Total Raised

$7.9M

Rounds

7

Convertible NoteSeptember 2023
Earnest Agriculture
Earnest Agriculture

Total Raised

$1.1M

Rounds

3

Seed$750kSeptember 2023
Calder Biosciences
Calder Biosciences
Seed

Total Raised

$8.9M

Rounds

8

Seed$525kSeptember 2023
QuantumCyte
QuantumCyte
Series A

Total Raised

$1.1M

Rounds

6

Series A$1.1MAugust 2023
Cell BioEngines
Cell BioEngines
Pre-Seed

Total Raised

$625k

Rounds

3

Pre-Seed$250kAugust 2023
Pre-Seed$275kMarch 2023
California Cultured
California Cultured
Series A

Total Raised

$4M

Rounds

4

Convertible NoteMay 2023
Stämm
Stämm
Series B

Total Raised

$17.2M

Rounds

7

Series BApril 2023
Beeflow
Beeflow
Series A

Total Raised

$11.8M

Rounds

5

Convertible NoteMarch 2023
Cayuga Biotech
Cayuga Biotech
Acquired

Total Raised

$250k

Rounds

4

SeedMarch 2023
Dnalite Therapeutics
Dnalite Therapeutics
Series A

Total Raised

$8.3M

Rounds

9

Convertible NoteMarch 2023
BiomeSense
BiomeSense
Series A

Total Raised

$12.6M

Rounds

11

Seed$3MFebruary 2023
Aluna
Aluna
Series B

Total Raised

$19M

Rounds

14

Series B$15.3MJanuary 2023
Maa'Va
Maa'Va

Total Raised

$525k

Rounds

2

SeedJanuary 2023
Michroma
Michroma
Seed

Total Raised

$7.1M

Rounds

5

Seed$6.4MJanuary 2023
Atlantic Fish
Atlantic Fish
Pre-Seed

Total Raised

$675k

Rounds

3

Pre-Seed$525kJanuary 2023
Cybele Microbiome
Cybele Microbiome
Angel

Total Raised

$375k

Rounds

6

Convertible NoteDecember 2022